INT-210 Capsule

DRUG2 trials

Sponsors

Innatus Therapeutics (Shanghai) Co., Ltd.

Conditions

IBD (Inflammatory Bowel Disease)Ulcerative Colitis (UC)

Phase 1

A Phase I Study of INT-210 Capsules in Healthy Adult Subjects (INT-210-I101)

CompletedNCT07616791

Innatus Therapeutics (Shanghai) Co., Ltd.IBD (Inflammatory Bowel Disease)

Start: 2025-09-04End: 2026-01-06Updated: 2026-06-01

A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis

RecruitingNCT07692165

Innatus Therapeutics (Shanghai) Co., Ltd.Ulcerative Colitis (UC)

Start: 2026-06-11End: 2028-06-01Target: 24Updated: 2026-07-09